Wedbush Forecasts Strong Price Appreciation for Tourmaline Bio (NASDAQ:TRML) Stock
Tourmaline Bio (NASDAQ:TRML – Free Report) had its price target lifted by Wedbush from $42.00 to $43.00 in a research report report published on Friday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock. Several other research analysts have also recently commented on TRML. Lifesci Capital assumed coverage on Tourmaline Bio in […]
Tourmaline Bio (NASDAQ:TRML – Free Report) had its price target lifted by Wedbush from $42.00 to $43.00 in a research report report published on Friday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock. Several other research analysts have also recently commented on TRML. Lifesci Capital assumed coverage on Tourmaline Bio in […]
